THE QUESTION I HAD NEVER ASKED IN SIX YEARS

Sarah's words sat with me long after she left.

In fifteen years of practice, I had heard every version of "what causes my migraines." from my paitents.

But What no patient had ever done was tell me they were done managing them.

That they wanted the source of them gone.

Until Sarah had.

And sitting there with her chart that night, I had to admit something I had been avoiding the whole time.

I had spent six years lowering her migraine count.

I had never once asked what was firing the migraines in the first place.

So that night I went looking.

I pulled Sarah's scans. Six years of pictures of what was actually happening inside her head while her migraines were firing.

Then I pulled a scan of a non-migraineur to compare them against.

And there it was.

In the non-migraineur it was clean. A single pathway running across the front of the face. Quiet most of the time. Firing only when it had a real reason to.

In a Sarah it looked like a tangle of messy cables. Wired into hundreds of surrounding nerve cords it should never have been talking to.

I realized this was the trigeminal nerve.

The nerve responsible for almost everything a person feels from their forehead to their jaw.

The nerve every neurologist points to when a patient asks where their migraines come from.

When it fires, the migraine fires.

I sat with the image for a long time.

And that was when something Sarah had told me at an appointment a few years back came back to me.

She had been telling me how it used to take a real trigger to set off a migraine.

Too much sleep. A skipped meal. The week before her period.

She had managed around those for years.

But then, things she had lived with her whole life had started setting them off.

The fluorescent lights in her firm's conference room. Her husband's cologne. The pressure change before a thunderstorm.

"I feel like existing is a trigger."

I had moved past it in the appointment. Adjusted her dose. And sent her on her way.

But now sitting in front of that image, I finally understood what she had been telling me.

Her triggers had not gotten worse.

Her nerve had.

And the medication I had been handing her for six years had never been touching it.

It had been suppressing everything around it instead.

Including the part of her she was quietly losing.

THE BRAIN FOG ISN'T A SIDE EFFECT

I pulled up her prescription history.

Six years of refills. Six years of dose adjustments. Six years of telling her the brain fog was the cost of the medication working.

And I had known the reason it cost her what it did the entire time.

The trigeminal nerve does not sit alone in the brain. It runs alongside almost everything responsible for clear thinking.

Word recall. Memory. Processing speed. Attention.

There is no medication that can reach this nerve without reaching everything wired in next to it.

Topamax? Slows the entire brain down so the nerve fires less often.

Amitriptyline? Sedates the nervous system so the nerve has less to react to.

Propranolol? Lowers cardiovascular response so the nerve has less fuel.

Botox? Paralyzes the muscles around the nerve so the firing can't reach the surface.

Four different medications. Four different ways of slowing down everything around the nerve.

Not one of them built to touch the nerve itself.

Every preventative I had ever handed Sarah was reaching her nerve through the part of her brain she used to think.

The brain fog wasn't the cost of treating her migraines. It was the cost of treating her migraines this way.

And it was the only way my field had ever bothered to build.

Not because it was the only way it could be done.

Because it was the only way that made anyone money.

A medication a patient takes every day for the rest of her life is a business model.

A treatment that calms her nerve and lets her stop is not.

So for thirty years, the medications stayed on the shelf.

The trade-off stayed in the side effects column.

And patient after patient was told the brain fog was the cost of fewer migraines.

If I wanted to give Sarah what she had asked for, I was going to have to look outside the playbook my field had handed me.

Because the answer was never going to come from inside it.

THE DISCOVERY THAT CHANGED EVERYTHING

For weeks I searched.

Not in the journals I had been trained to read. Those journals were never going to have what I was looking for.

So I dug through neuroscience journals my field had never told me to open. Looking for anything that worked directly on the trigeminal nerve.

Most threads led nowhere.

Then I found a 2016 study by Dr. Rami Burstein at Harvard Medical School. A neurologist who had spent his career on the trigeminal nerve.

Burstein's team had been studying why light triggers migraine attacks in the first place. They took chronic migraine patients into a darkened room, exposed them to different wavelengths of light one at a time, and measured what happened in the trigeminal nerve.

Every wavelength they tested — blue, red, white, amber — made the nerve fire harder.

But one wavelength didn't.

A narrow band of green light at exactly 520 nanometers.

Did the exact opposite

This wavelength made the same tangled nerve I had been seeing in my patients start resetting.

The effect was so undeniable that Burstein had included blind patients in the trial to rule out placebo. Patients who could not see the light at all.

The effect held in them at the same rate as the people who could see.

I needed to know if this would hold up beyond Harvard.

So I searched for every study that had cited Burstein's research.

A 2018 University of Arizona trial had replicated his findings on the patients every neurologist eventually gives up on — the ones who had failed Botox, CGRP injections, every medication available.

After ten weeks of daily green light exposure, those patients reported a 60% reduction in migraine days.

For the first time in fifteen years, I was looking at something that could reach the trigeminal nerve directly.

And I had only found it because I had stopped looking where my field had told me to look.

The question I had to answer next was simple.

How does light reach a nerve buried inside the head?

The answer was in the way the eye is wired.

How Green Light Therapy Actually Works

When 520nm light reaches your eyes, it passes through your eyelids and lands on your retina.

From there it travels down the optic nerve into the brain regions responsible for processing light and pain — including the regions that control your trigeminal nerve.

It is the only known wavelength that reaches the trigeminal nerve through this pathway directly.

Not through the bloodstream. Not through suppression of the brain around the nerve.

Through the visual system itself — even with your eyes closed.

Here is what happens at the neurological level once the signal arrives:

1. Triggers The Body's Own Pain-Relief System. Green light triggers the brain to release its own natural pain-relieving compounds. The same compounds the body produces when it manages pain on its own. Not delivered through the bloodstream. Not borrowed from a drug. Released by the body itself.

2. Dissolves The Wiring Around The Nerve. With consistent exposure, the new pathways the nerve has formed over years of migraines begin loosening. The tangle of cables I had watched build up in patient after patient was actually capable of decompressing. Like physical therapy for a nerve that had spent years wiring itself into everything around it.

3. Raises The Trigger Threshold. As the wiring loosens, the bar for what fires the nerve climbs back toward where it was before the migraines started compounding. Light, weather, food, hormones, stress — the triggers that had been firing attacks because the nerve had become wired to them — stop pushing the nerve over the edge.

This is not pain blocking.

This is not symptom management.

This is not slowing the brain around the nerve to reach it.

This is the only known mechanism that reaches the trigeminal nerve directly without suppressing anything else to get there.

The science was sound. The trials were peer-reviewed. The results were repeating across institutions.

There was only one problem left.

I needed a device that could actually deliver 520nm light at the precision the research required.

WHY MOST GREEN LIGHT DEVICES FAIL

So I started looking.

Lamps. Bulbs. Panels. Glasses. Anything claiming to deliver green light therapy.

Most I dismissed within minutes.

Not because green light therapy did not work.

Because they were not delivering true 520nm light.

A standard green light bulb emits a broad spectrum of wavelengths. The precise 520nm concentration the research used is nowhere in that range.

Device after device failed the same test.

Wrong wavelength. No clinical specifications. Not medical grade.

Nothing on the market met the standard the research required.

No medical device manufacturer had built it.

No pharmaceutical company had funded one.

The research had been sitting in journals for nearly a decade and nobody with the resources to bring it to a patient had bothered.

So my team made a decision.

If the right device did not exist we would build it ourselves.

We partnered with biomedical engineers who specialized in phototherapy and gave them one brief — replicate the exact conditions of the Harvard and Arizona trials in something patients could use at home.

Months of development. Rounds of testing. Version after version until it met the standard the research demanded.

Then we had it.

Vivée.

The device the medical industry had no reason to ever build.

Now in my patients' hands.

The Only Device That Reaches The Nerve

Vivée is a medical-grade green light therapy device, calibrated to exactly 520 nanometers — the same wavelength used in the Harvard and Arizona trials.

Designed as a soft, lightweight face mask. Worn over the eyes for ten minutes a day. Eyes open or closed.

Rechargeable. Quiet. No prescription. No setup.

Built to three specifications nobody else on the market was meeting:

✅ Precisely calibrated to 520nm. Narrow-band, not broad-spectrum. The exact wavelength the research validated.

✅ Clinical-grade light intensity. Calibrated to the same exposure level the trials used. Strong enough to reach the trigeminal nerve through the optic pathway, gentle enough for daily use.

✅ Designed for daily home use. No appointments. No ongoing prescriptions. Ten minutes a day, on your own time, in your own space.

This was not a wellness product. It was not a consumer lamp.

It was the first device built to do for a patient at home what the Harvard and Arizona trials had only been able to do in a research lab.

WHAT HAPPENED WHEN MY PATIENTS WENT GREEN

Sarah's annual appointment was the following month.

I told her everything. The trigeminal nerve. The gap in how her medication was reaching it.

What the Harvard researchers had found.

What the Arizona trial had shown.

She listened without any skepticism.

Then she said — "So there actually is another way."

I told her there was.

She decided to try it.

Sarah was not the only one.

Over the next year I started recommending Vivée to patients who were in the same place she had been.

Dependent on medication with unbearable side effects.

Here is what happened.

MARIA, 38-

Maria was 38 when she came to me after three years on Propranolol.

Her migraines were controlled. But she had gained nearly twenty pounds she could not lose no matter what she did.

Four workouts a week. Clean eating. Nothing moved.

She had stopped looking in the mirror the way she used to.

Six months after starting Vivée she had reduced her Propranolol to half her original dose with her neurologist's guidance.

She called me on a Tuesday morning and said -

"I did a spin class yesterday and I actually felt like myself doing it. I forgot what that was like."

LISA, 52-

Lisa was 52 and had been on Topamax for four years when she first came to see me.

Her migraines were fewer. But her hair had been thinning steadily since the first year.

Slowly enough that she kept telling herself it was something else. Something fixable.

It was not something else.

She had started avoiding mirrors. Avoided photographs. Stopped going to events she used to love because she did not feel like herself in them anymore.

Three months after starting Vivée and beginning to taper off her medication she sent me a photo.

No caption. Just a photo of herself at a birthday party smiling

In the past two years I've recommended Vivée to over 200 chronic migraine patients.

They had stopped believing fewer migraines and themselves could exist in the same place.

They could.

WHAT THIS MEANS FOR YOU

Imagine waking up and your first thought not being about whether today is a functioning day.

Just waking up.

Imagine sitting in a meeting and the words coming the way they used to.

Not reaching. Not waiting. Just there.

Imagine being the one in the room whose thoughts arrive first.

Whose sentences land clean.

Whose presence people notice — not because you are struggling to keep up but because you are ahead of everyone else again.

Imagine your children, your partner, your colleagues — getting the version of you that was there before all of this started.

Not a medicated version. Not a managed version.

The version of yourself the medication was never supposed to take.

THE CHOICE IS YOURS

Listen. I'm not telling you this to scare you.

I'm telling you because I have watched too many patients regret how long they waited.

So before you decide to think about it, here is what I want you to know.

The wiring around your trigeminal nerve doesn't stop building because you got used to the brain fog.

Every migraine between now and the day you decide to do something about it is another connection wiring itself in.

Which means another dose increase. Another medication added on top. Another year of the side effects controlling you.

The damage the medication has been masking has been compounding the entire time.

Sarah waited six years before she found another way.

Maria waited three.

Lisa waited four.

Every one of them said the same thing once they were no longer dependent on their medication:

"I should have done this years ago."

The only people who don't say that are the ones who started.

Try Vivée Risk-Free for 60 days

If you've decided you want to try addressing the nerve directly — here's what I recommend to my patients.

Vivée.

A device engineered to deliver the specific wavelength that reaches the trigeminal nerve directly. Without slowing the brain around it.

Ten minutes a day. That's it.

No prescriptions. No side effects. No monthly refills.

Vivée offers a 60 day money back guarantee.

That is enough time to see whether your migraine days are dropping. Whether your doctor agrees you can start reducing your dose. Whether the words start coming back the way they used to.

If it doesn't work for you — you pay nothing.

Compare that to:
   
     • 3 months of side effects before you know if it works

     • Preventative medications that stopped working ($600+ in prescriptions with insurance)

     • More migraine days each year despite doing everything right

With Vivée you either start going days without a migraine.

Or you get your money back.

You can try Vivée risk-free for 60 days.

A PERSONAL NOTE

I spent fifteen years being part of a system that was measuring the wrong thing.

I was counting migraine days. I was not asking what else was being counted in the process.

Sarah spent six years losing herself to a trade-off that never had to exist.

And she is not alone.

Every patient who comes into my office on long term migraine medication and describes the fog, the lost words, the version of themselves they keep reaching for and not quite finding — they were never told another option existed.

Now you know it exists.

What you do with that is entirely up to you.

— Dr. Maya Chen
Headache & Pain Specialist
15 years in practice | 3,000+ patients treated